Optibrium and Imperial College Collaborate for Drug Development for Neglected Diseases as part of project with DNDi Read more
US FDA ODAC recommends the approval of Pizer’s epoetin alfa biosimilar across all indications Read more
Ammonett Pharma Receives Notice of Allowance of U.S. Patent for “Detecting and treating GHD” Read more